← Leaderboards
Sergio A Jimenez
Thomas Jefferson University
$9,207,958
Attributed
$9,207,958
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$15,367,957 · 11
By mechanism
P01$6,470,567 · 2
R01$5,619,162 · 3
R21$1,993,422 · 5
T32$1,284,806 · 1
Top collaborators
No co-investigators on record.
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Robert G Knowlton$155,284
- Charlene J Williams$2,334,730
Others in their field
Top investigators on “Fibroblasts”
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$57,068,242
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$37,747,421
- Joseph C Wu · Stanford University$36,488,088
- Kristin Ardlie · Genomics Collaborative, Inc.$34,108,405
- Gail V Anderson · La Biomed Res Inst/ Harbor Ucla Med Ctr$27,497,410
- Joseph E Robertson · Oregon Health & Science University$27,496,135
Research focus
FibroblastsSystemic SclerodermaFibrosisSclerodermaCollagenGene ExpressionTissuesMolecularPathogenesisAffectSkinCellsEventLungOrganEndothelial CellsBaseCytokineLesionPathway InteractionsSignal TransductionPlayPhenotypeMediating
Grant awards (48)
Aptamer Proteomic Analysis of Systemic Sclerosis Serum Exosomes$181,661
R21 · FY2020 · AR · contact PI
Aptamer Proteomic Analysis of Systemic Sclerosis Serum Exosomes$229,784
R21 · FY2019 · AR · contact PI
Serum Exosome MicroRNA in Systemic Sclerosis$171,600
R21 · FY2018 · AR · contact PI
Serum Exosome MicroRNA in Systemic Sclerosis$205,920
R21 · FY2017 · AR · contact PI
Role of TRPV channels in the pathogenesis of Systemic Sclerosis vasculopathy$170,500
R21 · FY2015 · AR · contact PI
Role of TRPV channels in the pathogenesis of Systemic Sclerosis vasculopathy$81,249
R21 · FY2015 · AR · contact PI
Role of TRPV channels in the pathogenesis of Systemic Sclerosis vasculopathy$204,600
R21 · FY2014 · AR · contact PI
Role of toll like receptors (TLRs)in Gd contrast agent induced skin fibrosis$198,788
R21 · FY2013 · AR · contact PI
Role of Caveolin in Scleroderma Tissue Fibrosis and Vasculopathy$323,041
R01 · FY2012 · AR · contact PI
Role of toll like receptors (TLRs)in Gd contrast agent induced skin fibrosis$174,375
R21 · FY2012 · AR · contact PI
Role of Caveolin in Scleroderma Tissue Fibrosis and Vasculopathy$323,041
R01 · FY2011 · AR · contact PI
Identification of Novel Markers for Systemic Sclerosis Employing Proteomics$200,880
R21 · FY2011 · AR · contact PI
Role of Caveolin in Scleroderma Tissue Fibrosis and Vasculopathy$336,501
R01 · FY2010 · AR · contact PI
Biochemical and Vascular Alterations in Scleroderma$324,488
R01 · FY2010 · AR · contact PI
Identification of Novel Markers for Systemic Sclerosis Employing Proteomics$174,065
R21 · FY2010 · AR · contact PI
Role of Caveolin in Scleroderma Tissue Fibrosis and Vasculopathy$339,900
R01 · FY2009 · AR · contact PI
Biochemical and Vascular Alterations in Scleroderma$324,488
R01 · FY2009 · AR · contact PI
Biochemical and Vascular Alterations in Scleroderma$396,354
R01 · FY2008 · AR · contact PI
Role of Caveolin in Scleroderma Tissue Fibrosis and Vasculopathy$339,900
R01 · FY2008 · AR · contact PI
TRAINING IN MOLECULAR RHEUMATOLOGY AND ORTHOPEDICS$163,263
T32 · FY2008 · AR · contact PI
Biochemical and Vascular Alterations in Scleroderma$59,672
R01 · FY2008 · AR · contact PI
Biochemical and Vascular Alterations in Scleroderma$331,111
R01 · FY2007 · AR · contact PI
TRAINING IN MOLECULAR RHEUMATOLOGY AND ORTHOPEDICS$105,921
T32 · FY2007 · AR · contact PI
Molecular Biology of Osteoarthritis$1,077,191
P01 · FY2006 · AR · contact PI
Biochemical and Vascular Alterations in Scleroderma$341,000
R01 · FY2006 · AR · contact PI
TRAINING IN MOLECULAR RHEUMATOLOGY AND ORTHOPEDICS$159,382
T32 · FY2006 · AR · contact PI
Molecular Biology of Osteoarthritis$1,070,985
P01 · FY2005 · AR
TRAINING IN MOLECULAR RHEUMATOLOGY AND ORTHOPEDICS$171,302
T32 · FY2005 · AR
Molecular Biology of Osteoarthritis$1,045,760
P01 · FY2004 · AR
BIOCHEMICAL AND VASCULAR ALTERATIONS IN SCLERODERMA$298,920
R01 · FY2004 · AR
TRAINING IN MOLECULAR RHEUMATOLOGY AND ORTHOPEDICS$169,587
T32 · FY2004 · AR
Molecular Biology of Osteoarthritis$1,015,481
P01 · FY2003 · AR
BIOCHEMICAL AND VASCULAR ALTERATIONS IN SCLERODERMA$298,920
R01 · FY2003 · AR
TRAINING IN MOLECULAR RHEUMATOLOGY AND ORTHOPEDICS$48,364
T32 · FY2003 · AR
Molecular Biology of Osteoarthritis$994,351
P01 · FY2002 · AR
BIOCHEMICAL AND VASCULAR ALTERATIONS IN SCLERODERMA$298,920
R01 · FY2002 · AR
COLLAGEN METABOLISM IN A MODEL FOR SCLERODERMA$258,860
R01 · FY2002 · AR
EFFECTS OF MUTATIONS IN COLLAGEN GENES ON CARTILAGE MATRIX$155,284
P01 · FY2002 · AR
TRAINING IN MOLECULAR RHEUMATOLOGY AND ORTHOPEDICS$142,790
T32 · FY2002 · AR
BIOCHEMICAL AND VASCULAR ALTERATIONS IN SCLERODERMA$261,555
R01 · FY2001 · AR
COLLAGEN METABOLISM IN A MODEL FOR SCLERODERMA$253,209
R01 · FY2001 · AR
TRAINING IN MOLECULAR RHEUMATOLOGY AND ORTHOPEDICS$167,893
T32 · FY2001 · AR
TRAINING IN MOLECULAR RHEUMATOLOGY AND ORTHOPEDICS$2,722
T32 · FY2001 · AR
MOLECULAR BIOLOGY OF HERITABLE OSTEOARTHRITIS$956,231
P01 · FY2000 · AR
BIOCHEMICAL AND VASCULAR ALTERATIONS IN SCLERODERMA$261,555
R01 · FY2000 · AR
COLLAGEN METABOLISM IN A MODEL FOR SCLERODERMA$247,727
R01 · FY2000 · AR
EFFECTS OF MUTATIONS IN COLLAGEN AND COMP GENES ON CARTILAGE MATRIX$155,284
P01 · FY2000 · AR
TRAINING IN MOLECULAR RHEUMATOLOGY AND ORTHOPEDICS$153,582
T32 · FY2000 · AR